SCHEMBL22907285

SCHEMBL22907285

Fc1cc(-c2ccc(-c3cccnc3)cc2)cnc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
NPY5R Q15761 1/20 0.49
ERN1 O75460 1/20 0.47
MKNK1 Q9BUB5 3/20 0.46
MKNK2 Q9HBH9 3/20 0.46
EGFR P00533 1/20 0.46
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
CYP11B2 P19099 2/20 0.46
KIF11 P52732 1/20 0.46
CYP17A1 P05093 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP11B1 P15538 1/20 0.46
ABCB1 P08183 2/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNA5 P30532 1/20 0.46
CHRNA4 P43681 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16835804 0.79 FYN (0.52) CYP2A6ALDH1A1CYP1A2CYP3A4NPY5R
SCHEMBL1561209 0.79 CYP2A6 (0.52) CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1
SCHEMBL31403147 0.78 NPY5R (0.62) CYP2A6ALDH1A1CYP1A2CYP3A4NPY5R
SCHEMBL18876407 0.78 NPY5R (0.62) CYP2A6ALDH1A1CYP1A2CYP3A4NPY5R
SCHEMBL24534338 0.77 CYP2A6 (0.88) CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1
SCHEMBL29360677 0.77 CYP2A6 (0.88) CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1
SCHEMBL13907273 0.77 CYP2A6 (0.88) CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1
SCHEMBL16456302 0.76 TNKS (0.51) CYP2A6ALDH1A1CYP1A2CYP3A4PDGFRB
SCHEMBL18876264 0.76 CYP2A6 (0.62) CYP2A6ALDH1A1CYP1A2CYP3A4NPY5R
SCHEMBL2217759 0.76 CYP2A6 (0.62) CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011913-A1 TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2021-01-21 WO disclosed